Answers are grounded in this paper and cite their sources.
AIM: mutational status to determine how p53 mutations affect drug response and whether F10 is likely to improve outcomes. Resistance factors were derived from cell viability data and used to establish the relative potency advantage for F10. Rescue studies with exogenous uridine/thymidine determined if cytotoxicity resulted from DNA-directed processes. RESULTS: mutational status). F10 and 5-FU induce apoptosis by DNA- and RNA-directed mechanisms, respectively, and only F10 shows a modest enhancement in cytotoxicity upon co-treatment with leucovorin. CONCLUSION: mutations.6,7.
No takes yet. Share an insight, caveat, or question.
Dominijanni et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: